We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Assessment of Nonin 7600 Near Infrared Spectroscopy (NIRS) Tissue Oximetry During Cardiovascular Surgery

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01289470
First Posted: February 3, 2011
Last Update Posted: May 21, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Nonin Medical, Inc
  Purpose
An observational study designed to evaluate the performance of a new Near Infrared Spectroscopy (NIRS) tissue oximeter device in the clinical setting, including a cerebral sensor and peripheral sensor. Fifty patients who are undergoing open-heart surgery will be enrolled and tissue oximetry measurement will be collected throughout the surgical procedure and for up to 24 hours following surgery. Tissue oximeter measurement of the brain and skeletal tissue will be added to the standard intra-operative patient monitoring. Measures of delirium will be collected using a standardized questionnaire. The relationship between cerebral oximetry measures and delirium scores will be explored.

Condition
Heart; Dysfunction Postoperative, Cardiac Surgery

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Clinical Assessment of Nonin 7600 Near Infrared Spectroscopy (NIRS) Tissue Oximetry During Cardiovascular Surgery

Further study details as provided by Nonin Medical, Inc:

Primary Outcome Measures:
  • Percent of time Regional Oxygen Saturation (rSO2) values are registered during open heart surgery. [ Time Frame: Completion of cardiovascular surgery ]

Secondary Outcome Measures:
  • Correlation between delirium outcome scale and Regional Oxygen Saturation (rSO2) values. [ Time Frame: Patient discharge (on average 7 days) ]

Enrollment: 50
Study Start Date: January 2011
Study Completion Date: March 2012
Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
Detailed Description:
See Eligibility Criteria section
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients undergoing Coronary Artery Bypass Graft (CABG) and valvular surgery with cardiopulmonary bypass
Criteria

Inclusion Criteria:

  • Age 18 years or older
  • Weigh at least 40 kg
  • Undergoing Coronary Artery Bypass Graft (CABG) and/or valvular surgery requiring the use of Cardio Pulmonary Bypass (CPB) or Left Ventricular Assist Device (LVAD), inclusive of any concomitant procedure
  • Willing and able to provide informed consent
  • Able to communicate and read in English

Exclusion Criteria:

  • Emergency procedure such that informed consent may not be obtained
  • Known cognitive impairment, history of delirium or dementia
  • Known hemodialysis or fistula graft
  • Delirium Observation Score (DOS) Score of >6 prior to surgery
  • Pre-existing skin condition at the site of sensor application (e.g. eczema, dermatitis)
  • Any known contraindication or sensitivity to the cerebral oximeter sensor
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01289470


Locations
United States, North Carolina
Duke University Medical Center
Durham, North Carolina, United States, 27710
Sponsors and Collaborators
Nonin Medical, Inc
Investigators
Principal Investigator: Solomon Aronson, MD Duke University Health System
  More Information

Responsible Party: Nonin Medical, Inc
ClinicalTrials.gov Identifier: NCT01289470     History of Changes
Other Study ID Numbers: QATP1881
First Submitted: January 14, 2011
First Posted: February 3, 2011
Last Update Posted: May 21, 2012
Last Verified: May 2012

Keywords provided by Nonin Medical, Inc:
NIRS Technology
Cardiovascular surgery
valvular surgery with cardiopulmonary bypass